NEXT Oncology is a clinical research site located in Irving, Texas, United States 75039.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
NEXT Oncology has participated in 20 clinical trials with 16 currently active.
Therapeutic areas: RAS Mutation, NF1 Mutation, RAF Mutation.
Sponsors: Pasithea Therapeutics Corp., Merck Sharp & Dohme LLC, Harbour BioMed US, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Irving
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEXT Oncology has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT Oncology has 20 clinical trials on record, with 16 currently active. Their work covers RAS Mutation, NF1 Mutation, RAF Mutation.
NEXT Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.